Join your colleagues for the 21st Bio€quity Europe as industry leaders debate these questions and identify where Europe will continue to provide global leadership in biopharma innovation.

Registration includes:

• Three days of strategic panels focused on Europe's Next Act

• 130+ Presentations from European and Asian biotechs handpicked by BioCentury

• 1x1 virtual partnering using EBD's PartneringONE System

• European biotech executive report from Insights Partner, McKinsey & Co.

• Opportunities for digital networking

• Access to BioCentury business intelligence on European biotech and BioCentury BCIQ database to help you prepare for 1x1 virtual meetings with Presenting Companies and other attendees